Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Announces Last Patient Completed NCX 4251 Mississippi Phase 2b Blepharitis Trial

July 2, 2021

View Press Release Corporate presentation Contact us
Previous